Search research articles
Contact Us
Filters
Showing results (91-100 of 122) with videos related to
Page
of 13
Sort By:
Journal of Clinical Medicine
|
May 14, 2025
The Triglyceride-Glucose Index as a Biomarker for Insulin Resistance Following Hepatitis C Virus Eradication: A Prospective Cohort Study
Shih-Hsiung Shen, Hsin-Ju Tsai, Yu-Hsuan Li, et al.
Journal of Gastroenterology and Hepatology
|
March 3, 2025
Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg-Negative Chronic Hepatitis B
Cheng-Hao Tseng, Teng-Yu Lee, Chi-Yi Chen, et al.
Journal of Clinical Medicine
|
January 28, 2026
Serum Outperforms Plasma for Glypican-3 Quantification in Hepatocellular Carcinoma-A Prospective Comparative Study
Ming-Tze Yang, Jiunn-Min Wang, Chen-Shiou Wu, et al.
Journal of Clinical Medicine
|
December 23, 2023
Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients
Yi-Jie Huang, Tsai-Chung Li, Cheng-Hsu Chen, et al.
Scientific Reports
|
January 2, 2025
Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis
Yi-Jie Huang, Jun-Sing Wang, Cheng-Hsu Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
August 2, 2022
Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma
Chi-Ying Yang, Ro-Ting Lin, Chi-Yi Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 13, 2025
Predictive factors and clinical outcomes in decompensated non-cirrhotic chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate
Yi-Jie Huang, Jun-Sing Wang, Cheng-Hsu Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 11, 2026
Validated Nationwide Scoring System for Hepatocellular Carcinoma Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease
Teng-Yu Lee, Sherlot Juan Song, Hsiu J Ho, et al.
Plos One
|
January 10, 2017
Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma
Lu-Hung Lee, Jen-I Hwang, Yu-Chi Cheng, et al.
Antimicrobial Agents and Chemotherapy
|
December 13, 2021
Grazoprevir/Elbasvir Treatment in Liver or Kidney Transplant Recipients with Genotype 1b Hepatitis C Virus Infection
Ping-Chin Lai, Cheng-Hsu Chen, Long-Bin Jeng, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 122) with videos related to
Sort By:
Page
of 13
Journal of Clinical Medicine
|
May 14, 2025
The Triglyceride-Glucose Index as a Biomarker for Insulin Resistance Following Hepatitis C Virus Eradication: A Prospective Cohort Study
Shih-Hsiung Shen, Hsin-Ju Tsai, Yu-Hsuan Li, et al.
Journal of Gastroenterology and Hepatology
|
March 3, 2025
Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg-Negative Chronic Hepatitis B
Cheng-Hao Tseng, Teng-Yu Lee, Chi-Yi Chen, et al.
Journal of Clinical Medicine
|
January 28, 2026
Serum Outperforms Plasma for Glypican-3 Quantification in Hepatocellular Carcinoma-A Prospective Comparative Study
Ming-Tze Yang, Jiunn-Min Wang, Chen-Shiou Wu, et al.
Journal of Clinical Medicine
|
December 23, 2023
Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients
Yi-Jie Huang, Tsai-Chung Li, Cheng-Hsu Chen, et al.
Scientific Reports
|
January 2, 2025
Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis
Yi-Jie Huang, Jun-Sing Wang, Cheng-Hsu Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
August 2, 2022
Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma
Chi-Ying Yang, Ro-Ting Lin, Chi-Yi Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
May 13, 2025
Predictive factors and clinical outcomes in decompensated non-cirrhotic chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate
Yi-Jie Huang, Jun-Sing Wang, Cheng-Hsu Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 11, 2026
Validated Nationwide Scoring System for Hepatocellular Carcinoma Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease
Teng-Yu Lee, Sherlot Juan Song, Hsiu J Ho, et al.
Plos One
|
January 10, 2017
Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma
Lu-Hung Lee, Jen-I Hwang, Yu-Chi Cheng, et al.
Antimicrobial Agents and Chemotherapy
|
December 13, 2021
Grazoprevir/Elbasvir Treatment in Liver or Kidney Transplant Recipients with Genotype 1b Hepatitis C Virus Infection
Ping-Chin Lai, Cheng-Hsu Chen, Long-Bin Jeng, et al.
Page
of 13